In January 2026, the FDA approved oral semaglutide (Wegovy 25mg pill) as the first GLP-1 receptor agonist in pill form for chronic weight management. This marks a major shift in obesity treatment — patients now have an effective alternative to weekly injections.
How Much Weight Can You Lose?
Clinical trials show oral semaglutide achieves approximately 13.6% body weight loss over 64 weeks. While slightly less than the injectable version (which achieves 15-17%), the convenience of a daily pill dramatically improves adherence for many patients. In real-world Clyne data, patients on oral semaglutide lose an average of 29.3 lbs in the first six months when combined with diet and exercise.
How to Take It
Take the pill first thing in the morning on an empty stomach with no more than half a glass of water. Wait at least 30 minutes before eating, drinking, or taking other medications. This ensures proper absorption through the stomach lining.
Side Effects to Know
The most common side effects are gastrointestinal: nausea (affecting about 40% of patients initially), constipation, and diarrhea. These typically improve within 4-6 weeks as your body adjusts. Eating smaller, protein-rich meals can reduce nausea significantly.
Is It Right for You?
Oral semaglutide is prescribed for adults with a BMI of 30 or greater, or 27+ with at least one weight-related condition. A Clyne provider can evaluate your eligibility with a same-day online consultation.
Ready to get started?
Talk to a licensed physician and get a personalized treatment plan — from your phone.
Start your free visit with a licensed physicianMore from Weight Loss
Editorial standards
This content is reviewed by Clyne's editorial team and grounded in published clinical evidence. Citations are listed at the end of each piece. Clyne Concierge translates the science; your physician makes all clinical decisions. We never fabricate trial data, patient stories, or outcomes.
Last reviewed: